Keyword: breast cancer treatment
News
03.07.2014
- Swiss-based Roche Holding AG plans to pay up to $1.73 billion to buy Seragon Pharmaceuticals, a privately-held US biotech company that researches breast cancer treatments. Roche...
News
02.10.2013
- U.S. health regulators expanded the approval of Roche's breast cancer drug Perjeta and will now allow its use to help shrink tumors prior to surgery, the FDA said. The decision...
News
30.07.2012
- Novartis drug Afinitor, expected to become a major seller for the Swiss drugmaker, was approved by European regulators to treat women with a certain type of breast cancer, the...
